New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)
Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
California
-
Long Beach, California, United States, 90806
- Research Center
-
Los Angeles, California, United States, 90095
- Research Center
-
Los Angeles, California, United States, 90027
- Research Center
-
-
Connecticut
-
Hartford, Connecticut, United States, 06106
- Research Center
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Research Center
-
-
Florida
-
Gainesville, Florida, United States, 32610
- Research Center
-
-
Georgia
-
Atlanta, Georgia, United States, 30342
- Research Center
-
-
Illinois
-
Chicago, Illinois, United States, 60614
- Research Center
-
Park Ridge, Illinois, United States, 60068
- Research Center
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- Research Center
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Research Center
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Research Center
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Research Center
-
-
New Jersey
-
Camden, New Jersey, United States, 08103
- Research Center
-
-
New York
-
New York, New York, United States, 10021
- Research Center
-
New York, New York, United States, 10029
- Research Center
-
New York, New York, United States, 10032
- Research Center
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Research Center
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822
- Research Center
-
Philadelphia, Pennsylvania, United States, 19104
- Research Center
-
-
Texas
-
Austin, Texas, United States, 78701
- Research Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Other specific inclusion/exclusion criteria may apply. In order to determine eligibility, further examination by the investigator is necessary.
Inclusion Criteria:
- Hospitalized/chronic care pediatric patients (birth through 17 years)
- Known infections due to vancomycin-resistant enterococcus species, including diagnosis of hospital-acquired pneumonia, complicated skin and skin structure infections, catheter-related bacteremia, bacteremia of unidentified source, and other infections
- Requires a minimum of 3 days of IV medication
- Patients with mixed infections due to VRE & gram negative bacteria are allowed to enroll in the study. For most of the infections, 2 or more of additional symptoms are required.
Exclusion Criteria:
- Potentially effective concomitant antibiotic
- A high surgical cure rate
- Medical conditions which would preclude clinical evaluation or require treatment of longer duration than 28 days
- 24 hours of antibiotic treatment within 48 hours of study entry (unless pre-approved)
- Having an infected device that could not be removed
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
Investigator's and sponsor's evaluation of patient clinical outcome.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
|---|
|
Pathogen eradication rates, changes in clinical signs and symptoms, body temperature, WBC count, lesion size (for SSSIs) and chest radiograph findings(for HAP).
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- M12600082VRE
- A5951062
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.